Drugs / P128
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT01746654 | Dec 2012 → Oct 2015 | bacterial infectious disease | GangaGen, Inc. | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | P128 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01746654 ↗ |
| Modality | Protein / enzyme biologic | “antibacterial protein P128” NCT01746654 ↗ |
| Route | Intranasal | “the drug and placebo intra-nasally” NCT01746654 ↗ |